These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20332394)

  • 1. Aggressive glycemic control might not be best choice for all diabetic patients.
    Mitka M
    JAMA; 2010 Mar; 303(12):1137-8. PubMed ID: 20332394
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoglycemia and cardiovascular risk].
    Avogaro A
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
    Shubrook JH
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):Sii-1. PubMed ID: 21928545
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes. Insights from the extended follow-up of the ACCORD trial.
    Zoungas S; Woodward M
    Nat Rev Cardiol; 2011 Jun; 8(6):308-10. PubMed ID: 21502962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients.
    Karalliedde J; Gnudi L
    Nephrol Dial Transplant; 2008 Jun; 23(6):1796-8. PubMed ID: 18403430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 8. [New therapeutic approaches in type 2 diabetes mellitus].
    Zafon C
    Med Clin (Barc); 2015 Dec; 145(11):485-7. PubMed ID: 26142571
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.
    Dhar GC
    Can Fam Physician; 2009 Aug; 55(8):803-4. PubMed ID: 19675265
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials.
    Gaede P
    Pol Arch Med Wewn; 2008 Nov; 118(11):619-21. PubMed ID: 19140564
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines ease up on glycemic control for some patients with type 2 diabetes.
    Mitka M
    JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812
    [No Abstract]   [Full Text] [Related]  

  • 14. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive glucose lowering and cardiovascular outcomes.
    Winterstein AG; Heckbert SR; Schambelan M
    N Engl J Med; 2011 Jun; 364(23):2263; author reply 2264. PubMed ID: 21651404
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glycemic targets and cardiovascular morbi-mortality].
    Bordier L; Bauduceau B
    Presse Med; 2013 May; 42(5):855-60. PubMed ID: 23286961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.
    Fowler GC; Vasudevan DA
    South Med J; 2010 Sep; 103(9):911-6. PubMed ID: 20689486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic targets and cardiovascular disease.
    Cefalu WT
    N Engl J Med; 2008 Jun; 358(24):2633-5. PubMed ID: 18539919
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment urgency: The importance of getting people with type 2 diabetes to target promptly.
    Felton AM; LaSalle J; McGill M;
    Diabetes Res Clin Pract; 2016 Jul; 117():100-3. PubMed ID: 27329028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.